<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02001064</url>
  </required_header>
  <id_info>
    <org_study_id>Care4Today-13</org_study_id>
    <nct_id>NCT02001064</nct_id>
  </id_info>
  <brief_title>Care4Today v2.0 Application for Improving Adherence to HIV Medications</brief_title>
  <official_title>Pilot Study of Care4Today v.2.0 Application for Improving Adherence to HIV Medications</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Janssen Research &amp; Development, LLC</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although poor antiretroviral (ART) adherence in HIV does not mean a complete lack of&#xD;
      therapeutic results, the benefit of ART increases as adherence improves. Consequences of&#xD;
      suboptimal ART adherence are viral rebound, development of drug-resistant HIV strains, and&#xD;
      more rapid progression to AIDS. Moreover, HIV-infected persons tend to have numerous&#xD;
      co-occurring conditions and therefore take many medications making adherence to multiple drug&#xD;
      regimens more difficult. A mobile application capable of improving medication adherence among&#xD;
      HIV-infected persons would be highly useful.&#xD;
&#xD;
      The investigators propose an intervention study designed to address these potential&#xD;
      mechanisms of nonadherence by utilizing the Care4Today v2.0 smartphone application (app). The&#xD;
      current study is a small pilot Randomized Controlled Trial (RCT) comparing the smart phone&#xD;
      application titled &quot;Care4Today v2.0&quot; versus standard of care to improve medication adherence&#xD;
      to ART over a 4-week period with 60 HIV-infected participants.&#xD;
&#xD;
      The pilot RCT consists of 60 HIV-infected persons who are at risk for ART medication&#xD;
      nonadherence. Using random assignment, 30 HIV-infected participants will be assigned to&#xD;
      medication adherence improvement via &quot;Care4Today&quot; app as compared to 30 HIV-infected&#xD;
      participants assigned standard of care.&#xD;
&#xD;
      The investigators will assess the effectiveness and acceptability of the app in improving&#xD;
      objectively measured ART adherence (i.e., via medication event monitoring system caps) over a&#xD;
      4-week period via a pilot RCT with 30 HIV-infected persons assigned to the Care4Today&#xD;
      intervention and 30 HIV-infected persons assigned to standard of care.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants ≥90% Adherent to Antiretroviral Medication Based on MEMS Cap Openings</measure>
    <time_frame>Completion of 30-day intervention</time_frame>
    <description>Adherence will be measured using Medication Event Monitoring Systems (MEMS). Adherence defined as % MEMS adherence (doses taken/doses prescribed) within 2 hours of the indicated dose time. Adherence was dichotomized into 2 groups: &lt;90% and ≥90% using MEMS caps.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Average Minutes From Antiretroviral Medication Dose Time Based on MEMS Cap Openings</measure>
    <time_frame>Completion of 30-day intervention</time_frame>
    <description>The absolute value (in minutes) from the time a participant was scheduled to take an antiretroviral medication dose to when the participant opened the MEMS cap</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Doses Taken in Dose Time Window</measure>
    <time_frame>Completion of 30-day intervention</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>HIV</condition>
  <condition>AIDS</condition>
  <arm_group>
    <arm_group_label>Care4Today v2.0 mobile application + electronic monitoring of adherence</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Care4Today v2.0 mobile application&#xD;
Participants in the experimental application arm will use the Care4Today v2.0 mobile application for antiretroviral medication adherence support. Alert messages generated via the app will be targeted to the specific schedule and needs of the individual.&#xD;
Electronic monitoring of adherence:&#xD;
Participants' adherence to antiretroviral therapy medication is measured via Medication Event Monitoring System (MEMS) cap.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Electronic monitoring of adherence</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participants' adherence to antiretroviral therapy medication is measured via Medication Event Monitoring System (MEMS) cap.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Care4Today v2.0 mobile application + electronic monitoring of adherence</intervention_name>
    <description>Care4Today mobile application will send automated medication alert messages to HIV-infected persons. The alert messages are customizable and automated, and real-time results are viewable within the application. The Care4Today intervention is designed to improve adherence to ART medications among HIV-infected persons who experience adherence difficulties over standard of care.</description>
    <arm_group_label>Care4Today v2.0 mobile application + electronic monitoring of adherence</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ability to provide informed consent&#xD;
&#xD;
          -  18 years or older at the time of enrollment&#xD;
&#xD;
          -  HIV-infected&#xD;
&#xD;
          -  Taking at least one medication to treat HIV illness&#xD;
&#xD;
          -  Indication of medication nonadherence, or having a condition (e.g., active substance&#xD;
             use, depression) that puts the individual at risk for medication non adherence&#xD;
&#xD;
          -  Willingness to use electronic monitoring caps to track ART medication&#xD;
&#xD;
          -  Willingness to respond to application alert messages&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Axis I psychiatric diagnosis of psychotic disorder or mood disorder with psychotic&#xD;
             features&#xD;
&#xD;
          -  Presence of a neurological condition (beyond HIV infection) known to impact cognitive&#xD;
             functioning (e.g., Huntington's Disease, Stroke)&#xD;
&#xD;
          -  Unwillingness or inability to use electronic medication monitoring technology&#xD;
&#xD;
          -  Unwillingness or inability to use daily alert messages&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David J. Moore, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Diego</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hnrc-Tmarc</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>November 27, 2013</study_first_submitted>
  <study_first_submitted_qc>November 27, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2013</study_first_posted>
  <results_first_submitted>June 3, 2021</results_first_submitted>
  <results_first_submitted_qc>July 8, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">July 29, 2021</results_first_posted>
  <last_update_submitted>July 8, 2021</last_update_submitted>
  <last_update_submitted_qc>July 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>David J. Moore, Ph.D.</investigator_full_name>
    <investigator_title>Professor of Psychiatry</investigator_title>
  </responsible_party>
  <keyword>interventions</keyword>
  <keyword>technology</keyword>
  <keyword>adherence</keyword>
  <keyword>ARV</keyword>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>We enrolled 60 participants for the study cohort. 58 participants completed the initial assessment, 2 decided to discontinue after randomization (both did not wish to use the mobile application and phone for the duration of the study). Additionally, 1 participant decided to no longer participate in research studies between visits one and two.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Care4Today v2.0 Mobile Application + Electronic Monitoring of Adherence</title>
          <description>Care4Today v2.0 mobile application&#xD;
Participants in the experimental application arm will use the Care4Today v2.0 mobile application for antiretroviral medication adherence support. Alert messages generated via the app will be targeted to the specific schedule and needs of the individual.&#xD;
Electronic monitoring of adherence:&#xD;
Participants' adherence to antiretroviral therapy medication is measured via MEMS cap.</description>
        </group>
        <group group_id="P2">
          <title>Electronic Monitoring of Adherence</title>
          <description>Electronic monitoring of adherence:&#xD;
Participants' adherence to antiretroviral therapy medication is measured via MEMS cap.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="30"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Care4Today v2.0 Mobile Application + Electronic Monitoring of Adherence</title>
          <description>Care4Today v2.0 mobile application&#xD;
Participants in the experimental application arm will use the Care4Today v2.0 mobile application for antiretroviral medication adherence support. Alert messages generated via the app will be targeted to the specific schedule and needs of the individual.&#xD;
Electronic monitoring of adherence:&#xD;
Participants' adherence to antiretroviral therapy medication is measured via MEMS cap.</description>
        </group>
        <group group_id="B2">
          <title>Electronic Monitoring of Adherence</title>
          <description>Electronic monitoring of adherence:&#xD;
Participants' adherence to antiretroviral therapy medication is measured via MEMS cap.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="28"/>
            <count group_id="B2" value="29"/>
            <count group_id="B3" value="57"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="49.8" spread="9.6"/>
                    <measurement group_id="B2" value="48.5" spread="9.5"/>
                    <measurement group_id="B3" value="49.2" spread="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Non-Hispanic White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Non-Hispanic Black</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Education</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.9" spread="2.2"/>
                    <measurement group_id="B2" value="12.9" spread="2.9"/>
                    <measurement group_id="B3" value="13.4" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants ≥90% Adherent to Antiretroviral Medication Based on MEMS Cap Openings</title>
        <description>Adherence will be measured using Medication Event Monitoring Systems (MEMS). Adherence defined as % MEMS adherence (doses taken/doses prescribed) within 2 hours of the indicated dose time. Adherence was dichotomized into 2 groups: &lt;90% and ≥90% using MEMS caps.</description>
        <time_frame>Completion of 30-day intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Care4Today v2.0 Mobile Application + Electronic Monitoring of Adherence</title>
            <description>Care4Today v2.0 mobile application&#xD;
Participants in the experimental application arm will use the Care4Today v2.0 mobile application for antiretroviral medication adherence support. Alert messages generated via the app will be targeted to the specific schedule and needs of the individual.&#xD;
Electronic monitoring of adherence:&#xD;
Participants' adherence to antiretroviral therapy medication is measured via MEMS cap.</description>
          </group>
          <group group_id="O2">
            <title>Electronic Monitoring of Adherence</title>
            <description>Electronic monitoring of adherence:&#xD;
Participants' adherence to antiretroviral therapy medication is measured via MEMS cap.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants ≥90% Adherent to Antiretroviral Medication Based on MEMS Cap Openings</title>
          <description>Adherence will be measured using Medication Event Monitoring Systems (MEMS). Adherence defined as % MEMS adherence (doses taken/doses prescribed) within 2 hours of the indicated dose time. Adherence was dichotomized into 2 groups: &lt;90% and ≥90% using MEMS caps.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.32</p_value>
            <method>t-test, 1 sided</method>
            <param_type>Odds Ratio (OR)</param_type>
            <param_value>2.3</param_value>
            <ci_n_sides>2-Sided</ci_n_sides>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Average Minutes From Antiretroviral Medication Dose Time Based on MEMS Cap Openings</title>
        <description>The absolute value (in minutes) from the time a participant was scheduled to take an antiretroviral medication dose to when the participant opened the MEMS cap</description>
        <time_frame>Completion of 30-day intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Care4Today v2.0 Mobile Application + Electronic Monitoring of Adherence</title>
            <description>Care4Today v2.0 mobile application&#xD;
Participants in the experimental application arm will use the Care4Today v2.0 mobile application for antiretroviral medication adherence support. Alert messages generated via the app will be targeted to the specific schedule and needs of the individual.&#xD;
Electronic monitoring of adherence:&#xD;
Participants' adherence to antiretroviral therapy medication is measured via MEMS cap.</description>
          </group>
          <group group_id="O2">
            <title>Electronic Monitoring of Adherence</title>
            <description>Electronic monitoring of adherence:&#xD;
Participants' adherence to antiretroviral therapy medication is measured via MEMS cap.</description>
          </group>
        </group_list>
        <measure>
          <title>Average Minutes From Antiretroviral Medication Dose Time Based on MEMS Cap Openings</title>
          <description>The absolute value (in minutes) from the time a participant was scheduled to take an antiretroviral medication dose to when the participant opened the MEMS cap</description>
          <units>minutes from target dose time</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="112.0" spread="112.0"/>
                    <measurement group_id="O2" value="146.7" spread="101.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.073</p_value>
            <p_value_desc>Cohen's d (ranks) = -.049</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Percentage of Doses Taken in Dose Time Window</title>
        <time_frame>Completion of 30-day intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Care4Today v2.0 Mobile Application + Electronic Monitoring of Adherence</title>
            <description>Care4Today v2.0 mobile application&#xD;
Participants in the experimental application arm will use the Care4Today v2.0 mobile application for antiretroviral medication adherence support. Alert messages generated via the app will be targeted to the specific schedule and needs of the individual.&#xD;
Electronic monitoring of adherence:&#xD;
Participants' adherence to antiretroviral therapy medication is measured via MEMS cap.</description>
          </group>
          <group group_id="O2">
            <title>Electronic Monitoring of Adherence</title>
            <description>Electronic monitoring of adherence:&#xD;
Participants' adherence to antiretroviral therapy medication is measured via MEMS cap.</description>
          </group>
        </group_list>
        <measure>
          <title>Percentage of Doses Taken in Dose Time Window</title>
          <units>Percentage of doses taken in window</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="28"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="66.8" spread="27.0"/>
                    <measurement group_id="O2" value="57.5" spread="32.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.24</p_value>
            <p_value_desc>Cohen's d=0.31</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data were collected while participants were on study (i.e., 30 days)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Care4Today v2.0 Mobile Application + Electronic Monitoring of Adherence</title>
          <description>Care4Today v2.0 mobile application&#xD;
Participants in the experimental application arm will use the Care4Today v2.0 mobile application for antiretroviral medication adherence support. Alert messages generated via the app will be targeted to the specific schedule and needs of the individual.&#xD;
Electronic monitoring of adherence:&#xD;
Participants' adherence to antiretroviral therapy medication is measured via MEMS cap.</description>
        </group>
        <group group_id="E2">
          <title>Electronic Monitoring of Adherence</title>
          <description>Electronic monitoring of adherence:&#xD;
Participants' adherence to antiretroviral therapy medication is measured via MEMS cap.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="29"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="29"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="28"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>1) Small sample size; 2) Short time period; 3) MEMS adherence data based on # of cap openings, not directly whether the medication was ingested; 4) No group without psychoeducation component</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. David J Moore, Professor of Psychiatry</name_or_title>
      <organization>UCSD HIV Neurobehavioral Research Program (HNRP)</organization>
      <phone>619-543-5093</phone>
      <email>djmoore@ucsd.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

